Showing 60,241 - 60,260 results of 122,865 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.93s Refine Results
  1. 60241

    Table 3_Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018.docx by Huang Yu (5882174)

    Published 2025
    “…</p>Results<p>Linear regression analysis showed that each 1-point increase in CVH score was significantly associated with decreased levels of liver enzymes [ALT: −0.200 U/L (95% CI: −0.223, −0.176), AST: −0.043 U/L (−0.062, −0.024), GGT: −0.453 U/L (−0.509, −0.397), ALP: −0.310 U/L (−0.340, −0.281)] and increased levels of albumin [0.040 g/dL (0.036, 0.045)] and AST/ALT ratio [0.0056 (0.0051, 0.0061)]. …”
  2. 60242

    Table 1_Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018.docx by Huang Yu (5882174)

    Published 2025
    “…</p>Results<p>Linear regression analysis showed that each 1-point increase in CVH score was significantly associated with decreased levels of liver enzymes [ALT: −0.200 U/L (95% CI: −0.223, −0.176), AST: −0.043 U/L (−0.062, −0.024), GGT: −0.453 U/L (−0.509, −0.397), ALP: −0.310 U/L (−0.340, −0.281)] and increased levels of albumin [0.040 g/dL (0.036, 0.045)] and AST/ALT ratio [0.0056 (0.0051, 0.0061)]. …”
  3. 60243

    Table_1_Differences in Decision-Making Behavior Between Elite and Amateur Team-Handball Players in a Near-Game Test Situation.DOCX by Matthias Hinz (12398539)

    Published 2022
    “…To address this point, our study compared elite and amateur players’ decision-making behavior in a near-game test environment including sport-specific sensorimotor responses. …”
  4. 60244

    Diagnostic criteria for Alcoholic cardiomyopathy. by Fei Yan (128878)

    Published 2025
    “…</p><p><b>Results:</b> Globally, ACM burden showed significant declines from 1990 to 2021, with age-standardized rates decreasing by 22.5-37.1% across prevalence, mortality and disability measures. …”
  5. 60245

    Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  6. 60246

    Homogeneity test of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  7. 60247

    Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  8. 60248

    Analysis of variance of HbO<sub>2</sub> in bilateral PFC. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  9. 60249

    fNIRS equipment coordinates. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  10. 60250

    Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  11. 60251

    Analysis of variance of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  12. 60252

    Placement on the forehead. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  13. 60253

    IMW intervention plan design. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  14. 60254

    Results from phylogenetic profile comparison of 635,628 pairs of proteins chosen from among a subset of 1,191 yeast proteins by Raja Jothi (31820)

    Published 2011
    “…The relative performances of all but one (BAE4) reference sets of genomes for yeast are almost the same as that for . A gradual decrease in performance can be noticed as the fraction of eukaryotic genomes in the reference set increases (BAE4, BAE5, BAE6, AE, E), which is counter-intuitive considering the fact that one would hope to see an improved performance on adding more eukaryotic genomes. …”
  15. 60255

    CXCR3 antagonism-induced lowering of intraocular pressure prevents retinal neurodegeneration and protects visual function in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

    Published 2012
    “…<p><i>(A,B)</i> Ocular hypertension during 3 months is associated with a degradation in the visual function <i>(A)</i> as assessed by the duration of visual tracking during a 1-min optokinetic testing (spatial frequency, 0.5 cycle/degree), and with a decrease in retinal nerve fiber density <i>(B)</i> as measured <i>in vivo</i> by scanning light ophthalmoscopy. …”
  16. 60256

    BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System by Niklas Mattsson (144720)

    Published 2012
    “…In particular Aβ1-34 decreased, while Aβ5-40 increased, and these changes were more sensitive to BACE1 inhibition than the changes in Aβ1-40 and Aβ1-42. …”
  17. 60257

    Supplementary Material for: The Incidence and Risk Factors of Infusion-Related Reactions to Rituximab for Treating B Cell Malignancies in a Single Tertiary Hospital by Jung J.-W. (4141510)

    Published 2014
    “…<b><i>Results:</i></b> A total of 389 cases of IRRs by rituximab (12.5% of a total of 3,104 infusions) were identified in 281 patients (49.4% of a total of 568 patients). …”
  18. 60258

    The flow diagram of the eligible studies. by Hao Han (412732)

    Published 2024
    “…<div><p>Background</p><p>The long non-coding RNA cancer susceptibility candidate (CASC) has abnormal expression in lung cancer tissues and may correlate with lung cancer prognosis. …”
  19. 60259

    Data_Sheet_1_Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents.DOCX by Muriel Giron (13224453)

    Published 2022
    “…We had four experimental groups: control rats on an ad libitum diet (AL); non-supplemented rats on the food-restricted diet (R); and two sets of food-restricted rats that received a daily supplement of one of the strains (∼10<sup>9</sup> CFU; R+62 and R+63). …”
  20. 60260

    Data_Sheet_1_Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents.DOCX by Muriel Giron (13224453)

    Published 2023
    “…We had four experimental groups: control rats on an ad libitum diet (AL); non-supplemented rats on the food-restricted diet (R); and two sets of food-restricted rats that received a daily supplement of one of the strains (∼10<sup>9</sup> CFU; R+62 and R+63). …”